nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLCO1A2—Prednisolone—psoriatic arthritis	0.0893	0.11	CbGbCtD
Indinavir—SLCO1A2—Prednisone—psoriatic arthritis	0.0843	0.104	CbGbCtD
Indinavir—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0526	0.0647	CbGbCtD
Indinavir—ABCC1—Methotrexate—psoriatic arthritis	0.0474	0.0582	CbGbCtD
Indinavir—ABCC2—Dexamethasone—psoriatic arthritis	0.0436	0.0536	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—psoriatic arthritis	0.0423	0.052	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—psoriatic arthritis	0.0399	0.049	CbGbCtD
Indinavir—ABCB1—Methylprednisolone—psoriatic arthritis	0.0376	0.0462	CbGbCtD
Indinavir—ABCC2—Methotrexate—psoriatic arthritis	0.0351	0.0431	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0291	0.0358	CbGbCtD
Indinavir—CYP3A7—Dexamethasone—psoriatic arthritis	0.0291	0.0358	CbGbCtD
Indinavir—CYP2C19—Prednisone—psoriatic arthritis	0.0282	0.0347	CbGbCtD
Indinavir—ABCB1—Betamethasone—psoriatic arthritis	0.0245	0.03	CbGbCtD
Indinavir—ABCB1—Prednisolone—psoriatic arthritis	0.0241	0.0296	CbGbCtD
Indinavir—ABCB1—Prednisone—psoriatic arthritis	0.0228	0.028	CbGbCtD
Indinavir—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0225	0.0277	CbGbCtD
Indinavir—CYP3A5—Dexamethasone—psoriatic arthritis	0.0219	0.0268	CbGbCtD
Indinavir—CYP2C19—Dexamethasone—psoriatic arthritis	0.0176	0.0217	CbGbCtD
Indinavir—CYP3A4—Triamcinolone—psoriatic arthritis	0.0171	0.021	CbGbCtD
Indinavir—CYP2C9—Dexamethasone—psoriatic arthritis	0.0147	0.018	CbGbCtD
Indinavir—CYP3A4—Betamethasone—psoriatic arthritis	0.0147	0.018	CbGbCtD
Indinavir—CYP3A4—Prednisolone—psoriatic arthritis	0.0145	0.0178	CbGbCtD
Indinavir—ABCB1—Dexamethasone—psoriatic arthritis	0.0142	0.0175	CbGbCtD
Indinavir—CYP3A4—Prednisone—psoriatic arthritis	0.0137	0.0168	CbGbCtD
Indinavir—CYP2D6—Dexamethasone—psoriatic arthritis	0.0134	0.0165	CbGbCtD
Indinavir—ABCB1—Methotrexate—psoriatic arthritis	0.0114	0.014	CbGbCtD
Indinavir—CYP3A4—Dexamethasone—psoriatic arthritis	0.00852	0.0105	CbGbCtD
Indinavir—Myalgia—Triamcinolone—psoriatic arthritis	0.000232	0.00125	CcSEcCtD
Indinavir—Pneumonia—Methotrexate—psoriatic arthritis	0.000232	0.00125	CcSEcCtD
Indinavir—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000232	0.00125	CcSEcCtD
Indinavir—Myalgia—Methylprednisolone—psoriatic arthritis	0.000232	0.00125	CcSEcCtD
Indinavir—Anxiety—Methylprednisolone—psoriatic arthritis	0.000231	0.00124	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00023	0.00124	CcSEcCtD
Indinavir—Flushing—Prednisone—psoriatic arthritis	0.00023	0.00124	CcSEcCtD
Indinavir—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00023	0.00124	CcSEcCtD
Indinavir—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00023	0.00124	CcSEcCtD
Indinavir—Discomfort—Triamcinolone—psoriatic arthritis	0.00023	0.00123	CcSEcCtD
Indinavir—Discomfort—Methylprednisolone—psoriatic arthritis	0.000229	0.00123	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000229	0.00123	CcSEcCtD
Indinavir—Dry mouth—Triamcinolone—psoriatic arthritis	0.000227	0.00122	CcSEcCtD
Indinavir—Renal failure—Methotrexate—psoriatic arthritis	0.000227	0.00122	CcSEcCtD
Indinavir—Angioedema—Dexamethasone—psoriatic arthritis	0.000226	0.00122	CcSEcCtD
Indinavir—Angioedema—Betamethasone—psoriatic arthritis	0.000226	0.00122	CcSEcCtD
Indinavir—Immune system disorder—Prednisone—psoriatic arthritis	0.000224	0.0012	CcSEcCtD
Indinavir—Malaise—Betamethasone—psoriatic arthritis	0.000223	0.0012	CcSEcCtD
Indinavir—Malaise—Dexamethasone—psoriatic arthritis	0.000223	0.0012	CcSEcCtD
Indinavir—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000223	0.0012	CcSEcCtD
Indinavir—Oedema—Triamcinolone—psoriatic arthritis	0.000223	0.0012	CcSEcCtD
Indinavir—Vertigo—Betamethasone—psoriatic arthritis	0.000222	0.0012	CcSEcCtD
Indinavir—Vertigo—Dexamethasone—psoriatic arthritis	0.000222	0.0012	CcSEcCtD
Indinavir—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000222	0.0012	CcSEcCtD
Indinavir—Syncope—Betamethasone—psoriatic arthritis	0.000222	0.00119	CcSEcCtD
Indinavir—Syncope—Dexamethasone—psoriatic arthritis	0.000222	0.00119	CcSEcCtD
Indinavir—Sweating—Methotrexate—psoriatic arthritis	0.000221	0.00119	CcSEcCtD
Indinavir—Haematuria—Methotrexate—psoriatic arthritis	0.00022	0.00118	CcSEcCtD
Indinavir—Shock—Triamcinolone—psoriatic arthritis	0.000219	0.00118	CcSEcCtD
Indinavir—Insomnia—Prednisolone—psoriatic arthritis	0.000219	0.00118	CcSEcCtD
Indinavir—Alopecia—Prednisone—psoriatic arthritis	0.000219	0.00118	CcSEcCtD
Indinavir—Shock—Methylprednisolone—psoriatic arthritis	0.000219	0.00118	CcSEcCtD
Indinavir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000218	0.00117	CcSEcCtD
Indinavir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000218	0.00117	CcSEcCtD
Indinavir—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000218	0.00117	CcSEcCtD
Indinavir—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000218	0.00117	CcSEcCtD
Indinavir—Paraesthesia—Prednisolone—psoriatic arthritis	0.000217	0.00117	CcSEcCtD
Indinavir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000216	0.00116	CcSEcCtD
Indinavir—Malnutrition—Prednisone—psoriatic arthritis	0.000216	0.00116	CcSEcCtD
Indinavir—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000215	0.00116	CcSEcCtD
Indinavir—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000215	0.00116	CcSEcCtD
Indinavir—Myalgia—Dexamethasone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Indinavir—Myalgia—Betamethasone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Indinavir—Anxiety—Betamethasone—psoriatic arthritis	0.00021	0.00113	CcSEcCtD
Indinavir—Anxiety—Dexamethasone—psoriatic arthritis	0.00021	0.00113	CcSEcCtD
Indinavir—Discomfort—Betamethasone—psoriatic arthritis	0.000208	0.00112	CcSEcCtD
Indinavir—Discomfort—Dexamethasone—psoriatic arthritis	0.000208	0.00112	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—psoriatic arthritis	0.000208	0.00112	CcSEcCtD
Indinavir—Pain—Prednisolone—psoriatic arthritis	0.000207	0.00111	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—psoriatic arthritis	0.000207	0.00111	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—psoriatic arthritis	0.000207	0.00111	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—psoriatic arthritis	0.000205	0.00111	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000204	0.0011	CcSEcCtD
Indinavir—Vision blurred—Prednisone—psoriatic arthritis	0.000203	0.00109	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—psoriatic arthritis	0.000203	0.00109	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000203	0.00109	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000202	0.00109	CcSEcCtD
Indinavir—Oedema—Dexamethasone—psoriatic arthritis	0.000202	0.00109	CcSEcCtD
Indinavir—Oedema—Betamethasone—psoriatic arthritis	0.000202	0.00109	CcSEcCtD
Indinavir—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000202	0.00109	CcSEcCtD
Indinavir—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000202	0.00109	CcSEcCtD
Indinavir—Insomnia—Triamcinolone—psoriatic arthritis	0.000201	0.00108	CcSEcCtD
Indinavir—Insomnia—Methylprednisolone—psoriatic arthritis	0.000201	0.00108	CcSEcCtD
Indinavir—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0002	0.00108	CcSEcCtD
Indinavir—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0002	0.00108	CcSEcCtD
Indinavir—Feeling abnormal—Prednisolone—psoriatic arthritis	0.0002	0.00107	CcSEcCtD
Indinavir—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.0002	0.00107	CcSEcCtD
Indinavir—Anaemia—Prednisone—psoriatic arthritis	0.000199	0.00107	CcSEcCtD
Indinavir—Shock—Betamethasone—psoriatic arthritis	0.000199	0.00107	CcSEcCtD
Indinavir—Shock—Dexamethasone—psoriatic arthritis	0.000199	0.00107	CcSEcCtD
Indinavir—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000199	0.00107	CcSEcCtD
Indinavir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000198	0.00107	CcSEcCtD
Indinavir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000198	0.00107	CcSEcCtD
Indinavir—Agitation—Prednisone—psoriatic arthritis	0.000198	0.00107	CcSEcCtD
Indinavir—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000198	0.00106	CcSEcCtD
Indinavir—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000198	0.00106	CcSEcCtD
Indinavir—Angioedema—Prednisone—psoriatic arthritis	0.000197	0.00106	CcSEcCtD
Indinavir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000196	0.00105	CcSEcCtD
Indinavir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000196	0.00105	CcSEcCtD
Indinavir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000196	0.00105	CcSEcCtD
Indinavir—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000195	0.00105	CcSEcCtD
Indinavir—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000195	0.00105	CcSEcCtD
Indinavir—Malaise—Prednisone—psoriatic arthritis	0.000194	0.00105	CcSEcCtD
Indinavir—Vertigo—Prednisone—psoriatic arthritis	0.000194	0.00104	CcSEcCtD
Indinavir—Syncope—Prednisone—psoriatic arthritis	0.000193	0.00104	CcSEcCtD
Indinavir—Anorexia—Dexamethasone—psoriatic arthritis	0.000193	0.00104	CcSEcCtD
Indinavir—Anorexia—Betamethasone—psoriatic arthritis	0.000193	0.00104	CcSEcCtD
Indinavir—Urticaria—Prednisolone—psoriatic arthritis	0.000192	0.00103	CcSEcCtD
Indinavir—Fatigue—Triamcinolone—psoriatic arthritis	0.000192	0.00103	CcSEcCtD
Indinavir—Fatigue—Methylprednisolone—psoriatic arthritis	0.000192	0.00103	CcSEcCtD
Indinavir—Pain—Triamcinolone—psoriatic arthritis	0.00019	0.00102	CcSEcCtD
Indinavir—Loss of consciousness—Prednisone—psoriatic arthritis	0.00019	0.00102	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—psoriatic arthritis	0.000187	0.00101	CcSEcCtD
Indinavir—Chills—Methotrexate—psoriatic arthritis	0.000186	0.000999	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000184	0.00099	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000184	0.00099	CcSEcCtD
Indinavir—Arthralgia—Prednisone—psoriatic arthritis	0.000184	0.000987	CcSEcCtD
Indinavir—Myalgia—Prednisone—psoriatic arthritis	0.000184	0.000987	CcSEcCtD
Indinavir—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000184	0.000987	CcSEcCtD
Indinavir—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000183	0.000985	CcSEcCtD
Indinavir—Anxiety—Prednisone—psoriatic arthritis	0.000183	0.000984	CcSEcCtD
Indinavir—Alopecia—Methotrexate—psoriatic arthritis	0.000183	0.000984	CcSEcCtD
Indinavir—Insomnia—Dexamethasone—psoriatic arthritis	0.000183	0.000983	CcSEcCtD
Indinavir—Insomnia—Betamethasone—psoriatic arthritis	0.000183	0.000983	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000182	0.000981	CcSEcCtD
Indinavir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000182	0.000977	CcSEcCtD
Indinavir—Paraesthesia—Betamethasone—psoriatic arthritis	0.000181	0.000976	CcSEcCtD
Indinavir—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000181	0.000976	CcSEcCtD
Indinavir—Discomfort—Prednisone—psoriatic arthritis	0.000181	0.000975	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—psoriatic arthritis	0.00018	0.000969	CcSEcCtD
Indinavir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000178	0.00096	CcSEcCtD
Indinavir—Dyspepsia—Betamethasone—psoriatic arthritis	0.000178	0.000957	CcSEcCtD
Indinavir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000178	0.000957	CcSEcCtD
Indinavir—Urticaria—Triamcinolone—psoriatic arthritis	0.000177	0.000952	CcSEcCtD
Indinavir—Urticaria—Methylprednisolone—psoriatic arthritis	0.000177	0.000949	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—psoriatic arthritis	0.000176	0.000949	CcSEcCtD
Indinavir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000176	0.000947	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000176	0.000946	CcSEcCtD
Indinavir—Oedema—Prednisone—psoriatic arthritis	0.000176	0.000946	CcSEcCtD
Indinavir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000176	0.000945	CcSEcCtD
Indinavir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000176	0.000945	CcSEcCtD
Indinavir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000176	0.000945	CcSEcCtD
Indinavir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000174	0.000938	CcSEcCtD
Indinavir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000174	0.000938	CcSEcCtD
Indinavir—Back pain—Methotrexate—psoriatic arthritis	0.000174	0.000938	CcSEcCtD
Indinavir—Fatigue—Betamethasone—psoriatic arthritis	0.000174	0.000937	CcSEcCtD
Indinavir—Fatigue—Dexamethasone—psoriatic arthritis	0.000174	0.000937	CcSEcCtD
Indinavir—Shock—Prednisone—psoriatic arthritis	0.000173	0.000931	CcSEcCtD
Indinavir—Pain—Dexamethasone—psoriatic arthritis	0.000173	0.000929	CcSEcCtD
Indinavir—Pain—Betamethasone—psoriatic arthritis	0.000173	0.000929	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—psoriatic arthritis	0.000173	0.000928	CcSEcCtD
Indinavir—Skin disorder—Prednisone—psoriatic arthritis	0.000171	0.000919	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00017	0.000915	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—psoriatic arthritis	0.00017	0.000913	CcSEcCtD
Indinavir—Anorexia—Prednisone—psoriatic arthritis	0.000168	0.000902	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000167	0.000899	CcSEcCtD
Indinavir—Anaemia—Methotrexate—psoriatic arthritis	0.000167	0.000896	CcSEcCtD
Indinavir—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000167	0.000896	CcSEcCtD
Indinavir—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000167	0.000896	CcSEcCtD
Indinavir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000165	0.000889	CcSEcCtD
Indinavir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000165	0.000889	CcSEcCtD
Indinavir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000164	0.000882	CcSEcCtD
Indinavir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000164	0.000881	CcSEcCtD
Indinavir—Malaise—Methotrexate—psoriatic arthritis	0.000163	0.000874	CcSEcCtD
Indinavir—Vertigo—Methotrexate—psoriatic arthritis	0.000162	0.000871	CcSEcCtD
Indinavir—Urticaria—Betamethasone—psoriatic arthritis	0.000161	0.000863	CcSEcCtD
Indinavir—Urticaria—Dexamethasone—psoriatic arthritis	0.000161	0.000863	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00016	0.000862	CcSEcCtD
Indinavir—Dizziness—Prednisolone—psoriatic arthritis	0.00016	0.000861	CcSEcCtD
Indinavir—Asthenia—Triamcinolone—psoriatic arthritis	0.00016	0.000859	CcSEcCtD
Indinavir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00016	0.000859	CcSEcCtD
Indinavir—Abdominal pain—Betamethasone—psoriatic arthritis	0.00016	0.000859	CcSEcCtD
Indinavir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00016	0.000859	CcSEcCtD
Indinavir—Body temperature increased—Betamethasone—psoriatic arthritis	0.00016	0.000859	CcSEcCtD
Indinavir—Asthenia—Methylprednisolone—psoriatic arthritis	0.000159	0.000857	CcSEcCtD
Indinavir—Insomnia—Prednisone—psoriatic arthritis	0.000159	0.000856	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—psoriatic arthritis	0.000158	0.00085	CcSEcCtD
Indinavir—Pruritus—Triamcinolone—psoriatic arthritis	0.000158	0.000847	CcSEcCtD
Indinavir—Cough—Methotrexate—psoriatic arthritis	0.000157	0.000846	CcSEcCtD
Indinavir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000157	0.000846	CcSEcCtD
Indinavir—Dyspepsia—Prednisone—psoriatic arthritis	0.000155	0.000833	CcSEcCtD
Indinavir—Chest pain—Methotrexate—psoriatic arthritis	0.000153	0.000825	CcSEcCtD
Indinavir—Myalgia—Methotrexate—psoriatic arthritis	0.000153	0.000825	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—psoriatic arthritis	0.000153	0.000825	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—psoriatic arthritis	0.000153	0.000823	CcSEcCtD
Indinavir—Rash—Prednisolone—psoriatic arthritis	0.000153	0.000821	CcSEcCtD
Indinavir—Dermatitis—Prednisolone—psoriatic arthritis	0.000153	0.00082	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000152	0.000819	CcSEcCtD
Indinavir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000152	0.000818	CcSEcCtD
Indinavir—Fatigue—Prednisone—psoriatic arthritis	0.000152	0.000816	CcSEcCtD
Indinavir—Headache—Prednisolone—psoriatic arthritis	0.000152	0.000816	CcSEcCtD
Indinavir—Discomfort—Methotrexate—psoriatic arthritis	0.000152	0.000815	CcSEcCtD
Indinavir—Constipation—Prednisone—psoriatic arthritis	0.00015	0.000809	CcSEcCtD
Indinavir—Dizziness—Triamcinolone—psoriatic arthritis	0.000147	0.000792	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000147	0.000791	CcSEcCtD
Indinavir—Dizziness—Methylprednisolone—psoriatic arthritis	0.000147	0.00079	CcSEcCtD
Indinavir—Feeling abnormal—Prednisone—psoriatic arthritis	0.000145	0.00078	CcSEcCtD
Indinavir—Asthenia—Dexamethasone—psoriatic arthritis	0.000145	0.00078	CcSEcCtD
Indinavir—Asthenia—Betamethasone—psoriatic arthritis	0.000145	0.00078	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000144	0.000776	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000144	0.000774	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000144	0.000774	CcSEcCtD
Indinavir—Nausea—Prednisolone—psoriatic arthritis	0.000144	0.000774	CcSEcCtD
Indinavir—Pruritus—Dexamethasone—psoriatic arthritis	0.000143	0.000769	CcSEcCtD
Indinavir—Pruritus—Betamethasone—psoriatic arthritis	0.000143	0.000769	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—psoriatic arthritis	0.000143	0.000768	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000142	0.000765	CcSEcCtD
Indinavir—Vomiting—Triamcinolone—psoriatic arthritis	0.000142	0.000762	CcSEcCtD
Indinavir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000141	0.00076	CcSEcCtD
Indinavir—Rash—Triamcinolone—psoriatic arthritis	0.00014	0.000755	CcSEcCtD
Indinavir—Dermatitis—Triamcinolone—psoriatic arthritis	0.00014	0.000755	CcSEcCtD
Indinavir—Anorexia—Methotrexate—psoriatic arthritis	0.00014	0.000754	CcSEcCtD
Indinavir—Rash—Methylprednisolone—psoriatic arthritis	0.00014	0.000754	CcSEcCtD
Indinavir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00014	0.000753	CcSEcCtD
Indinavir—Urticaria—Prednisone—psoriatic arthritis	0.00014	0.000752	CcSEcCtD
Indinavir—Headache—Triamcinolone—psoriatic arthritis	0.00014	0.00075	CcSEcCtD
Indinavir—Headache—Methylprednisolone—psoriatic arthritis	0.000139	0.000749	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—psoriatic arthritis	0.000139	0.000748	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—psoriatic arthritis	0.000139	0.000748	CcSEcCtD
Indinavir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000138	0.000744	CcSEcCtD
Indinavir—Diarrhoea—Betamethasone—psoriatic arthritis	0.000138	0.000744	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000134	0.000721	CcSEcCtD
Indinavir—Dizziness—Betamethasone—psoriatic arthritis	0.000134	0.000719	CcSEcCtD
Indinavir—Dizziness—Dexamethasone—psoriatic arthritis	0.000134	0.000719	CcSEcCtD
Indinavir—Insomnia—Methotrexate—psoriatic arthritis	0.000133	0.000715	CcSEcCtD
Indinavir—Nausea—Triamcinolone—psoriatic arthritis	0.000132	0.000711	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—psoriatic arthritis	0.000132	0.00071	CcSEcCtD
Indinavir—Nausea—Methylprednisolone—psoriatic arthritis	0.000132	0.00071	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—psoriatic arthritis	0.000131	0.000705	CcSEcCtD
Indinavir—Somnolence—Methotrexate—psoriatic arthritis	0.000131	0.000703	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—psoriatic arthritis	0.00013	0.000697	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—psoriatic arthritis	0.000129	0.000696	CcSEcCtD
Indinavir—Vomiting—Dexamethasone—psoriatic arthritis	0.000128	0.000691	CcSEcCtD
Indinavir—Vomiting—Betamethasone—psoriatic arthritis	0.000128	0.000691	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—psoriatic arthritis	0.000128	0.000688	CcSEcCtD
Indinavir—Rash—Dexamethasone—psoriatic arthritis	0.000127	0.000685	CcSEcCtD
Indinavir—Rash—Betamethasone—psoriatic arthritis	0.000127	0.000685	CcSEcCtD
Indinavir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000127	0.000685	CcSEcCtD
Indinavir—Dermatitis—Betamethasone—psoriatic arthritis	0.000127	0.000685	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000127	0.000683	CcSEcCtD
Indinavir—Fatigue—Methotrexate—psoriatic arthritis	0.000127	0.000682	CcSEcCtD
Indinavir—Headache—Dexamethasone—psoriatic arthritis	0.000127	0.000681	CcSEcCtD
Indinavir—Headache—Betamethasone—psoriatic arthritis	0.000127	0.000681	CcSEcCtD
Indinavir—Asthenia—Prednisone—psoriatic arthritis	0.000126	0.000679	CcSEcCtD
Indinavir—Pain—Methotrexate—psoriatic arthritis	0.000126	0.000676	CcSEcCtD
Indinavir—Pruritus—Prednisone—psoriatic arthritis	0.000125	0.00067	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000121	0.000652	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—psoriatic arthritis	0.00012	0.000648	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00012	0.000647	CcSEcCtD
Indinavir—Nausea—Betamethasone—psoriatic arthritis	0.00012	0.000646	CcSEcCtD
Indinavir—Nausea—Dexamethasone—psoriatic arthritis	0.00012	0.000646	CcSEcCtD
Indinavir—Urticaria—Methotrexate—psoriatic arthritis	0.000117	0.000628	CcSEcCtD
Indinavir—Dizziness—Prednisone—psoriatic arthritis	0.000116	0.000626	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000116	0.000625	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000116	0.000625	CcSEcCtD
Indinavir—Vomiting—Prednisone—psoriatic arthritis	0.000112	0.000602	CcSEcCtD
Indinavir—Rash—Prednisone—psoriatic arthritis	0.000111	0.000597	CcSEcCtD
Indinavir—Dermatitis—Prednisone—psoriatic arthritis	0.000111	0.000596	CcSEcCtD
Indinavir—Headache—Prednisone—psoriatic arthritis	0.00011	0.000593	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000108	0.000583	CcSEcCtD
Indinavir—Asthenia—Methotrexate—psoriatic arthritis	0.000106	0.000568	CcSEcCtD
Indinavir—Nausea—Prednisone—psoriatic arthritis	0.000105	0.000562	CcSEcCtD
Indinavir—Pruritus—Methotrexate—psoriatic arthritis	0.000104	0.00056	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000101	0.000541	CcSEcCtD
Indinavir—Dizziness—Methotrexate—psoriatic arthritis	9.73e-05	0.000523	CcSEcCtD
Indinavir—Vomiting—Methotrexate—psoriatic arthritis	9.35e-05	0.000503	CcSEcCtD
Indinavir—Rash—Methotrexate—psoriatic arthritis	9.27e-05	0.000499	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—psoriatic arthritis	9.26e-05	0.000498	CcSEcCtD
Indinavir—Headache—Methotrexate—psoriatic arthritis	9.21e-05	0.000496	CcSEcCtD
Indinavir—Nausea—Methotrexate—psoriatic arthritis	8.74e-05	0.00047	CcSEcCtD
